Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Total Current Liabilities came in at $88.5 million in Q1 2026, down 40.2% year-on-year from $147.9 million in Q1 2025, and down 18.85% quarter-over-quarter from $109.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Current Liabilities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $88.5 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 40.2% year-over-year to $88.5 million in Q1 2026; TTM through Mar 2026 was $88.5 million, a 40.2% decrease from a year earlier, with the FY2025 full-year figure at $109.0 million, down 24.58% from the prior year.
- Total Current Liabilities slipped to $88.5 million in Q1 2026 per AAWH's latest filing, from $109.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $147.9 million in Q1 2025 and bottomed at $88.5 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $109.8 million (2023), against an average of $116.2 million.
- Across the five-year window, Total Current Liabilities jumped 55.95% in 2024 and plunged 40.2% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $110.9 million in 2022, then slipped by 16.46% to $92.7 million in 2023, then soared by 55.95% to $144.5 million in 2024, then decreased by 24.58% to $109.0 million in 2025, then decreased by 18.85% to $88.5 million in 2026.
- Per Business Quant, the three latest AAWH Total Current Liabilities figures stand at $88.5 million (Q1 2026), $109.0 million (Q4 2025), and $96.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 88.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.46 Mn |
| Dec 31, 2025 | 109.01 Mn |
| Sep 30, 2025 | 96.00 Mn |
| Jun 30, 2025 | 100.79 Mn |
| Mar 31, 2025 | 147.92 Mn |
| Dec 31, 2024 | 144.54 Mn |
| Sep 30, 2024 | 145.13 Mn |
| Jun 30, 2024 | 103.06 Mn |
| Mar 31, 2024 | 103.44 Mn |
| Dec 31, 2023 | 92.69 Mn |
| Sep 30, 2023 | 129.76 Mn |
| Jun 30, 2023 | 124.65 Mn |
| Mar 31, 2023 | 109.81 Mn |
| Dec 31, 2022 | 110.95 Mn |
| Sep 30, 2022 | 137.50 Mn |
| Jun 30, 2022 | 122.04 Mn |
| Mar 31, 2022 | 109.33 Mn |
| Dec 31, 2021 | 117.40 Mn |
| Sep 30, 2021 | 104.89 Mn |
| Jun 30, 2021 | 110.22 Mn |